Therapeutic potential of human adipose stem cells in a rat myocardial infarction model
- PMID: 20046516
- PMCID: PMC2799983
- DOI: 10.3349/ymj.2010.51.1.69
Therapeutic potential of human adipose stem cells in a rat myocardial infarction model
Abstract
Purpose: Stem cell transplantation is expected to have good effects in the treatment of myocardial infarction (MI). We tested the effect of the transplantation of human adipose-derived cells (ASCs) in Sprague-Dawley (SD) rats with myocardial infarctions.
Materials and methods: ASCs were isolated from the waste of elective abdominal surgery. The MI model was set up in SD rats by permanent ligation of the left anterior descending coronary artery. One week after MI, either 1 x 10(6) ASCs or an equal volume of phosphate-buffered saline (PBS) was injected into the infarct zone. Cardiac function was assessed by echocardiography, 1 day, 1 week, 2 weeks, and 4 weeks after treatment. Four weeks after transplantation, immunohistochemistry was performed.
Results: Left ventricular function, including fractional shortening (FS), and ejection fraction (EF) showed a significant improvement in the ASCs transplantation group compared to the PBS group 4 weeks after treatment (p < 0.05). The anterior wall thickness of the left ventricle was significantly thicker in the ASCs transplantation group compared to the PBS group (p < 0.01). Multiple troponin T staining, and irregular, small amounts of connexin 43 expression also was observed in the ASCs transplantation group. Infarcted myocardium showed higher capillary density in the ASCs transplantation group than in the PBS injected group (p < 0.01).
Conclusion: This study provides encouraging evidence that transplantation of ASCs can improve cardiac function of infarct myocardium in rat models with a limitation of cardiac remodeling, improved wall thickness, and increased neovascularization.
Keywords: Myocardial infarction; stem cells; transplantation.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures
Similar articles
-
Adipose-derived stromal cell therapy improves cardiac function after coronary occlusion in rats.Cell Transplant. 2012;21(9):1985-96. doi: 10.3727/096368912X636858. Epub 2012 Apr 2. Cell Transplant. 2012. PMID: 22472303
-
Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.Acta Biochim Biophys Sin (Shanghai). 2011 Nov;43(11):857-66. doi: 10.1093/abbs/gmr087. Epub 2011 Oct 6. Acta Biochim Biophys Sin (Shanghai). 2011. PMID: 21983658
-
Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function.J Thorac Cardiovasc Surg. 2007 Nov;134(5):1249-58. doi: 10.1016/j.jtcvs.2007.07.028. J Thorac Cardiovasc Surg. 2007. PMID: 17976457
-
Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction.Chin Med J (Engl). 2009 Jan 20;122(2):183-7. doi: 10.3901/jme.2009.07.183. Chin Med J (Engl). 2009. PMID: 19187644
-
Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models.Stem Cell Rev Rep. 2014 Jun;10(3):389-98. doi: 10.1007/s12015-014-9502-7. Stem Cell Rev Rep. 2014. PMID: 24577790 Review.
Cited by
-
Reprogramming of single-cell-derived mesenchymal stem cells into hair cell-like cells.Otol Neurotol. 2012 Dec;33(9):1648-55. doi: 10.1097/MAO.0b013e3182713680. Otol Neurotol. 2012. PMID: 23111404 Free PMC article.
-
Cardiac Adipose Tissue Contributes to Cardiac Repair: a Review.Stem Cell Rev Rep. 2021 Aug;17(4):1137-1153. doi: 10.1007/s12015-020-10097-4. Epub 2021 Jan 3. Stem Cell Rev Rep. 2021. PMID: 33389679 Review.
-
Adipose-Derived Mesenchymal Stem Cell Transplantation in Chemotherapy-Induced Premature Ovarian Insufficiency: the Role of Connexin and Pannexin.Reprod Sci. 2022 Apr;29(4):1316-1331. doi: 10.1007/s43032-021-00718-9. Epub 2021 Aug 27. Reprod Sci. 2022. PMID: 34449073
-
Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.Stem Cells Dev. 2012 Oct 10;21(15):2770-8. doi: 10.1089/scd.2012.0176. Epub 2012 Jul 3. Stem Cells Dev. 2012. PMID: 22621212 Free PMC article. Review.
-
Harnessing the secretome of adipose-derived stem cells in the treatment of ischemic heart diseases.Stem Cell Res Ther. 2019 Jun 27;10(1):196. doi: 10.1186/s13287-019-1289-7. Stem Cell Res Ther. 2019. PMID: 31248452 Free PMC article. Review.
References
-
- Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol. 2004;44:464–466. - PubMed
-
- Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23:845–856. - PubMed
-
- Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 2004;14:311–324. - PubMed
-
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical